Similar Articles
CARDIOVASCULAR INVOLVEMENT IN RHEUMATOID ARTHRITIS
Elif Berber Menekşe, Ferhan Cantürk, Gamze Alaylı
Paraoxonase and Arylesterase Activities in Patients with Rheumatoid Arthritis
Özlem Altındağ, Mehmet Karakoç, Neslihan Soran, Hakim Çelik, Necla Çelik, Şahabettin Selek
Subclinical Atherosclerosis in Behçet's Disease
Samia HASSAN, Tamer GHEITA, Shada GHONEIM, Loi NASR
DOI: 10.5606/tjr.2012.016
Systemic Sclerosis is Not Associated with Increased Coronary Artery Calcium Deposition
Lee SEUNG-GEUN, Park YOUNG-EUN, Choi SU-YEON, Park EUN-KYUNG, Kim GEUN-TAE, Choo KI-SEOK, Jeong YEON-JOO
DOI: 10.5606/tjr.2013.3625
Increased Epicardial Fat Tissue Is a Marker of Subclinic Atherosclerosis in Ankylosing Spondylitis
Nilgun ÜSTÜN, Mustafa KURT, Nesrin ATCI, Erman YAĞIZ, Hayal GÜLER, Ayse TURHANOĞLU
DOI: 10.5606/ArchRheumatol.2014.4606
Association of Plasma Homocysteine Level and Carotid Intima-Media Thickness in Rheumatoid Arthritis Patients Receiving Methotrexate
Emrullah HAYTA, Sami HİZMETLİ, Mehmet Haydar ATALAR, Ziynet ÇINAR
DOI: 10.5606/ArchRheumatol.2015.4249
Glutathione-S-Transferase Variants are not Associated With Increased Carotid Intima-Media Thickness in Turkish Familial Mediterranean Fever Patients
Özlem GÜRBÜZ, Binnur BAĞCI, Can HÜZMELİ, Gökhan BAĞCI, Ferhan CANDAN
DOI: 10.5606/ArchRheumatol.2016.5628
Increased Carotid Intima-Media Thickness in Female Patients With Fibromyalgia: A Preliminary Study
Hüma BÖLÜK, Gökhan Tuna ÖZTÜRK, Didem CÖMERT, Murat ERSÖZ
DOI: 10.5606/ArchRheumatol.2015.5639
Sensorineural Hearing Impairment and Subclinical Atherosclerosis in Rheumatoid Arthritis Patients Without Traditional Cardiovascular Risk Factors
Hector MACIAS-REYES, Sergio DURAN-BARRAGAN, Cynthia R. CARDENAS-CONTRERAS, Cesar G. CHAVEZ-MARTIN, Eduardo GOMEZ-BAÑUELOS, Rosa E. NAVARRO-HERNANDEZ, Carlos O. YANOWSKY-GONZALEZ, Laura GONZALEZ-LOPEZ, Jorge I. GAMEZ-NAVA, Monica VAZQUEZ-DEL MERCADO
DOI: 10.5606/ArchRheumatol.2016.5739
Evaluation of Atrial Conduction Times, Epicardial Fat Thickness and Carotid Intima-Media Thickness in Patients With Ankylosing Spondylitis
Sabri Onur ÇAĞLAR, İsmail BOYRAZ, Fatma ERDEM, Selma YAZICI, Hilal ÇAĞLAR, Bünyamin KOÇ, Emrah ÇAĞLAR, Mehmet YAZICI
DOI: 10.5606/ArchRheumatol.2016.5867
Development of Atherosclerotic Cardiovascular Mortality in Gouty Arthritis and Rheumatoid Arthritis Patients: Are They Associated With Mean Platelet Volume and Neutrophil-Lymphocyte Ratio? A Comparative Study
Muhammet MADEN, Gülsüm Emel PAMUK, Ömer Nuri PAMUK
DOI: 10.5606/ArchRheumatol.2017.6033
Biomarkers of Cardiovascular Disease in Patients With Ankylosing Spondylitis
Ümit SARP, Evren ÜSTÜNER, Sehim KUTLAY, Şebnem ATAMAN, Sim KUTLAY
DOI: 10.46497/ArchRheumatol.2020.7868
Knowledge of cardiovascular disease risk in rheumatoid arthritis patients before and after educational intervention from a Southeast Asia country: Malaysia
Boon Ching TEOH, Syed Azhar SYED SULAIMAN, Bee Eng TAN
DOI: 10.46497/ArchRheumatol.2021.7726
Assessment of subclinical atherosclerosis with ankle-brachial index in psoriatic arthritis: A case-control study
Serhad BİLİM, Afitap İÇAĞASIOĞLU, Ayla AKBAL, Esen KASAPOĞLU, Sıdıka GÜRSEL
DOI: 10.46497/ArchRheumatol.2021.8083
Ultrasonographic measurement of the vascular wall thickness and intima-media thickness in patients with Behçet’s disease with symptoms or signs of vascular involvement: A cross-sectional study
Serdar KAYMAZ, Halil YILMAZ, Furkan UFUK, Ayşe Rüksan ÜTEBEY, Veli ÇOBANKARA, Uğur KARASU, Canan ALBAYRAK YAŞAR, Firdevs ULUTAŞ
DOI: 10.46497/ArchRheumatol.2021.8423
Investigation of Genes Associated With Atherosclerosis in Patients With Systemic Lupus Erythematosus
Mehmet Ali BALCI, Engin ATLI, Hakan GüRKAN
DOI: 10.46497/ArchRheumatol.2021.8024
The effects of glucocorticoid treatment on cardiovascular system in patients with systemic lupus erythematosus
Dominika Blachut, Brygida Przywara-Chowaniec, Jan Harpula, Andrzej Tomasik, Ewa Nowalany-Kozielska, Beata Morawiec
DOI: 10.46497/ArchRheumatol.2022.9255
Muscle architecture in patients with primary Sjögren syndrome
Duygu Tecer, Dilek Eker Büyüksireci, Zafer Günendi, Jale Meray, Feride Göğüs
DOI: 10.46497/ArchRheumatol.2023.9414
Proprotein convertase subtilisin/kexin 9 (PCSK9) in patients with diffuse systemic sclerosis: A marker of disease activity and severe disease manifestations with potential therapeutic implementations
Joy Artin, Yumn A. Elsabagh, Laila Rashed, Mohamed A. Hussein
DOI: 10.46497/ArchRheumatol.2023.9638